当前位置:
X-MOL 学术
›
Lancet Respir. Med.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Antihypertensive drugs and risk of COVID-19?
The Lancet Respiratory Medicine ( IF 76.2 ) Pub Date : 2020-03-26 , DOI: 10.1016/s2213-2600(20)30158-2 Joshua D Brown 1
The Lancet Respiratory Medicine ( IF 76.2 ) Pub Date : 2020-03-26 , DOI: 10.1016/s2213-2600(20)30158-2 Joshua D Brown 1
Affiliation
Lei Fang and colleagues extrapolated results from a molecular study of coronaviruses, which showed that this group of viruses uses angiotensin-converting enzyme 2 (ACE2) to target cells on the epithelium of the lungs, intestine, kidneys, and blood vessels. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes coronavirus disease 2019 (COVID-19), would probably share these properties.
中文翻译:
降压药和COVID-19的风险?
Lei Fang及其同事从冠状病毒的分子研究中推断了结果,结果表明这组病毒使用血管紧张素转化酶2(ACE2)靶向肺,肠,肾和血管上皮细胞。导致2019年冠状病毒病(COVID-19)的严重急性呼吸系统综合症冠状病毒2(SARS-CoV-2)可能具有这些特性。
更新日期:2020-03-27
中文翻译:
降压药和COVID-19的风险?
Lei Fang及其同事从冠状病毒的分子研究中推断了结果,结果表明这组病毒使用血管紧张素转化酶2(ACE2)靶向肺,肠,肾和血管上皮细胞。导致2019年冠状病毒病(COVID-19)的严重急性呼吸系统综合症冠状病毒2(SARS-CoV-2)可能具有这些特性。